Postby rp1954 » Wed Jul 29, 2015 6:11 pm
We've gotten these baseline biomarkers, preferably (insistently), most usefully before surgery: CEA, CA19-9, AFP, CA125, CA72-4, fibrinogen, quantitative d-dimer.
Our basic blood data, CMP-CBC, have also included LDH, hsCRP, ESR, HgbA1C, 25-hydroxyvitamin D, abbreviated 25(OH)D, for more thorough evaluations.
Sooner or later, some of these relatively low cost "extras" have made critical differences that standard care missed or couldn't provide, and saved us a wad of money, mistakes and misery. We repeated the CEA, CA19-9 and any elevated biomarkers 7-11 days after surgery to help evaluate the degree of cancer removal.
Serum CA19-9 can be important for several reasons, including long term cimetidine decisions for pre-op values in the 20+s when combined with elevated CEA or KRAS mutants. The other biomarkers may have meaning either in the present, albeit less commonly than CEA, for less common CRC variants, and in the future, when dealing with evolutions.
For female with advanced CRC, we used cimetidine up to 1600 mg/day with 15000-30,000 iu per day of vitamin D3 before surgeries to replete vitamin D deficiencies, a common, gross deficiency for CRC patients. Guys sometimes toleratED less daily cimetidine. With the surgeon substituting out the newer proton pump inhibitors for prophyllaxis of acid aspiration, even higher dose cimetidine was used for surgery itself.
watchful, active researcher and caregiver for stage IVb/c CC. surgeries 4/10 sigmoid etc & 5/11 para-aortic LN cluster; 8 yrs immuno-Chemo for mCRC; now no chemo
most of 2010 Life Extension recommendations and possibilities + more, some (much) higher, peaking ~2011-12, taper chemo to almost nothing mid 2018, IV C-->2021. Now supplements